Company Profile

Advanced Diagnostic Technologies LLC
Profile last edited on: 11/19/18      CAGE: 648K7      UEI:

Business Identifier: Non-invasive biomedical sensing.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2062 Alameda Padre Serra 101
Santa Barbara, CA 93103
   (805) 962-5501
Location: Single
Congr. District: 24
County: Santa Barbara

Public Profile

Early detection of abnormal physiologic parameters and signs of pathology are paramount to the successful implementation of countermeasures that can mitigate the probability of an adverse outcome. Advanced Diagnostic Technologies was working on a Spectroscopic Biosensor able non-invasively to measure target blood analytes with a multivariate approach Depolarization Raman, Absorption, and Scattering coefficients. By remove the requirements for maintaining biologic samples for monitoring a person's health, the system would enable real-time health monitoring. Small in size, easy to use, low in power, be portable. system could provide continuous -- or near continuous -- target analyte monitoring. Target analyte data could be stored and tranmitted as data. Biomedical sensing can be sued to measure specific hormone levels associated with excessive stress, insomnia and psychiatric disorders; measure blood analytes associated with malnutrition ; Noninvasive monitoring. Point-Of-Care device for: Doctor’s office, Home Health Care Agencies, Hospital laboratories, ICU monitoring, Telemedicine client

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 2 DHA $867,446
Project Title: 3D Printed Digital nanocomposite synthetic tissue
2014 2 DHA $876,111
Project Title: 3D Printed heterogeneously integrated sensors embedded in Anatomical training models
2013 1 NSF $149,480
Project Title: Novel partial cellular reprogramming method for the production of ex vivo blood
2011 1 NASA $99,980
Project Title: In-Flight Non-Invasive Sensing of Blood Analytes

Key People / Management

  Jonathon S Barton -- CEO

  Cristopher Geiler -- President

Company News

There are no news available.